OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Viral Vector Vaccine Development and Application during the COVID-19 Pandemic
Shaofeng Deng, Hui Liang, Chen Pin, et al.
Microorganisms (2022) Vol. 10, Iss. 7, pp. 1450-1450
Open Access | Times Cited: 68
Shaofeng Deng, Hui Liang, Chen Pin, et al.
Microorganisms (2022) Vol. 10, Iss. 7, pp. 1450-1450
Open Access | Times Cited: 68
Showing 26-50 of 68 citing articles:
Scrub typhus, a mite-borne rickettsiosis: innovative approaches for intervention strategies
R Paramasivan
Deleted Journal (2024) Vol. 1, Iss. 1
Open Access | Times Cited: 1
R Paramasivan
Deleted Journal (2024) Vol. 1, Iss. 1
Open Access | Times Cited: 1
Next Generation RNA/Protein‐Carrying Vector With Pleiotropic Activity
Tetsuya Nosaka, Junpei Ohtsuka, Tomomi Ohtsuka, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 6
Open Access | Times Cited: 1
Tetsuya Nosaka, Junpei Ohtsuka, Tomomi Ohtsuka, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 6
Open Access | Times Cited: 1
Novel receptor, mutation, vaccine, and establishment of coping mode for SARS-CoV-2: current status and future
Zhaomu Zeng, Xiuchao Geng, Xichao Wen, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 4
Zhaomu Zeng, Xiuchao Geng, Xichao Wen, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 4
COVID-19 Incidence Proportion as a Function of Regional Testing Strategy, Vaccination Coverage, and Vaccine Type
Арег А. Тотолян, В. С. Смирнов, Alexei A. Krasnov, et al.
Viruses (2023) Vol. 15, Iss. 11, pp. 2181-2181
Open Access | Times Cited: 4
Арег А. Тотолян, В. С. Смирнов, Alexei A. Krasnov, et al.
Viruses (2023) Vol. 15, Iss. 11, pp. 2181-2181
Open Access | Times Cited: 4
Comparative safety analysis of mRNA and adenoviral vector COVID-19 vaccines: a nationwide cohort study using an emulated target trial approach
Min Joo Choi, Yewon Na, Hakjun Hyun, et al.
Clinical Microbiology and Infection (2023) Vol. 30, Iss. 5, pp. 646-652
Closed Access | Times Cited: 4
Min Joo Choi, Yewon Na, Hakjun Hyun, et al.
Clinical Microbiology and Infection (2023) Vol. 30, Iss. 5, pp. 646-652
Closed Access | Times Cited: 4
COVID-19: Post infection implications in different age groups, mechanism, diagnosis, effective prevention, treatment, and recommendations
Muhammad Akmal Raheem, Muhammad Ajwad Rahim, Ijaz Gul, et al.
Life Sciences (2024), pp. 122861-122861
Open Access | Times Cited: 1
Muhammad Akmal Raheem, Muhammad Ajwad Rahim, Ijaz Gul, et al.
Life Sciences (2024), pp. 122861-122861
Open Access | Times Cited: 1
Adenovirus Encoded Adjuvant (AdEnA) anti-CTLA-4, a novel strategy to improve Adenovirus based vaccines against infectious diseases and cancer
Anna Morena D’Alise, Linda Nocchi, Irene Garzia, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Anna Morena D’Alise, Linda Nocchi, Irene Garzia, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Mucosal delivery of nanovaccine strategy against COVID-19 and its variants
Junwoo Lee, Dongwoo Khang
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 7, pp. 2897-2925
Open Access | Times Cited: 5
Junwoo Lee, Dongwoo Khang
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 7, pp. 2897-2925
Open Access | Times Cited: 5
Adenovirus Vaccine Containing Truncated SARS-CoV-2 Spike Protein S1 Subunit Leads to a Specific Immune Response in Mice
Keda Chen, Danrong Shi, Chaonan Li, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 429-429
Open Access | Times Cited: 2
Keda Chen, Danrong Shi, Chaonan Li, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 429-429
Open Access | Times Cited: 2
COVID-19 Vaccination and Serological Profile of a Brazilian University Population
Marina dos Santos Barreto, Beatriz Soares da Silva, Ronaldy Santana Santos, et al.
Life (2023) Vol. 13, Iss. 9, pp. 1925-1925
Open Access | Times Cited: 2
Marina dos Santos Barreto, Beatriz Soares da Silva, Ronaldy Santana Santos, et al.
Life (2023) Vol. 13, Iss. 9, pp. 1925-1925
Open Access | Times Cited: 2
Humoral and cellular immune responses analysis using FTIR spectroscopy on newborns of mothers vaccinated against COVID-19 with mRNA or viral vector vaccine
Mónica Maribel Mata-Miranda, Adriana Martínez-Cuazitl, Hermes Gutierrez-Cortes, et al.
Research Square (Research Square) (2024)
Open Access
Mónica Maribel Mata-Miranda, Adriana Martínez-Cuazitl, Hermes Gutierrez-Cortes, et al.
Research Square (Research Square) (2024)
Open Access
New approaches to vaccines for infectious diseases
Bagwe Priyal, Vijayanand Sharon, Patil Smital, et al.
Elsevier eBooks (2024), pp. 341-356
Closed Access
Bagwe Priyal, Vijayanand Sharon, Patil Smital, et al.
Elsevier eBooks (2024), pp. 341-356
Closed Access
New approaches to vaccines for autoimmunity
Vivek P. Chavda, Niva Rani Gogoi, Yesha Shah, et al.
Elsevier eBooks (2024), pp. 391-414
Closed Access
Vivek P. Chavda, Niva Rani Gogoi, Yesha Shah, et al.
Elsevier eBooks (2024), pp. 391-414
Closed Access
The fast-track development of COVID-19 vaccines
Yousra A. El‐Maradny, Asmaa Ramadan, Vivek P. Chavda, et al.
Elsevier eBooks (2024), pp. 415-440
Closed Access
Yousra A. El‐Maradny, Asmaa Ramadan, Vivek P. Chavda, et al.
Elsevier eBooks (2024), pp. 415-440
Closed Access
Analisa Kinerja Rantai Pasok: Studi Kasus Keberhasilan Pemenuhan Kebutuhan Vaksin di Industri Farmasi XYZ
Vandie Charlie, Sriwidodo Sriwidodo, Mas Rahman Roestan, et al.
Majalah Farmasetika (2024) Vol. 9, Iss. 3, pp. 255-255
Open Access
Vandie Charlie, Sriwidodo Sriwidodo, Mas Rahman Roestan, et al.
Majalah Farmasetika (2024) Vol. 9, Iss. 3, pp. 255-255
Open Access
Development of a high-performance liquid chromatography using rhodamine B hydrazide as the derivatization reagent for determination of β propiolactone residues in inactivated COVID-19 vaccines
Seyedeh Zohreh Mirjalili, Fatemeh Chavoshi, Mohsen Amini, et al.
Journal of Chromatography B (2024) Vol. 1244, pp. 124241-124241
Closed Access
Seyedeh Zohreh Mirjalili, Fatemeh Chavoshi, Mohsen Amini, et al.
Journal of Chromatography B (2024) Vol. 1244, pp. 124241-124241
Closed Access
Analysis of the immune response using FTIR spectroscopy in mothers and their newborns with different vaccination schemes for COVID-19
Mónica Maribel Mata-Miranda, Adriana Martínez-Cuazitl, Hermes Gutierrez-Cortes, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Mónica Maribel Mata-Miranda, Adriana Martínez-Cuazitl, Hermes Gutierrez-Cortes, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
A Theoretical and Statistical Comparison of Major COVID-19 Vaccines
Krishna Subramony Iyer
Journal of Student Research (2024) Vol. 13, Iss. 1
Open Access
Krishna Subramony Iyer
Journal of Student Research (2024) Vol. 13, Iss. 1
Open Access
Current Insights on Vaccines available for COVID-19 like Flu Symptoms
Abhishek Singh, Nimisha Nimisha, Niharika Singh, et al.
Research Journal of Pharmacy and Technology (2024), pp. 2967-2974
Closed Access
Abhishek Singh, Nimisha Nimisha, Niharika Singh, et al.
Research Journal of Pharmacy and Technology (2024), pp. 2967-2974
Closed Access
Trends in Viral Vector-Based Vaccines for Tuberculosis: A Patent Review (2010–2023)
Lana C. Santos, Antônio Márcio Santana Fernandes, Izabel Almeida Alves, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 876-876
Open Access
Lana C. Santos, Antônio Márcio Santana Fernandes, Izabel Almeida Alves, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 876-876
Open Access
Safety pharmacology of human endogenous retrovirus-enveloped baculoviral DNA vaccines against SARS-CoV-2 in Sprague-Dawley rats and beagle dogs
Sang‐Jin Park, Joung‐Wook Seo, Kang-Hyun Han, et al.
Vaccine X (2024) Vol. 20, pp. 100545-100545
Open Access
Sang‐Jin Park, Joung‐Wook Seo, Kang-Hyun Han, et al.
Vaccine X (2024) Vol. 20, pp. 100545-100545
Open Access
COVID-19 Vaccines and Adverse Effects of SARS-CoV-2 in Recovered Patients of COVID-19: An In-depth Review
B N Raghavendra, Sudhakar Kancharla, Prachetha Kolli, et al.
Journal of Pure and Applied Microbiology (2024) Vol. 18, Iss. 3, pp. 1424-1437
Open Access
B N Raghavendra, Sudhakar Kancharla, Prachetha Kolli, et al.
Journal of Pure and Applied Microbiology (2024) Vol. 18, Iss. 3, pp. 1424-1437
Open Access
Influenza B Virus Vaccine Innovation through Computational Design
Matthew J. Pekarek, Eric A. Weaver
Pathogens (2024) Vol. 13, Iss. 9, pp. 755-755
Open Access
Matthew J. Pekarek, Eric A. Weaver
Pathogens (2024) Vol. 13, Iss. 9, pp. 755-755
Open Access
Assessment of Neutralizing Antibodies Against COVID-19: The Impact of Vaccination in Western Rajasthan
Varsha Choudhary, Prabhat Kiran Khatri, Palak Khinvasara, et al.
Indian Journal of Clinical Biochemistry (2024)
Closed Access
Varsha Choudhary, Prabhat Kiran Khatri, Palak Khinvasara, et al.
Indian Journal of Clinical Biochemistry (2024)
Closed Access
The role of COVID-19 vaccination
Elissa Lin, Bahar Behrouzi, Jacob A. Udell
Elsevier eBooks (2024), pp. 275-313
Closed Access
Elissa Lin, Bahar Behrouzi, Jacob A. Udell
Elsevier eBooks (2024), pp. 275-313
Closed Access
